TY - JOUR
T1 - Early outcomes of Pyrocardan (R) implants for trapeziometacarpal osteoarthritis
AU - Lauwers, T. M. A. S.
AU - Brouwers, K.
AU - Staal, H.
AU - Hoekstra, L. T.
AU - van der Hulst, R. R. W. J.
PY - 2016/12
Y1 - 2016/12
N2 - The aim of this retrospective study was to assess the early outcomes of trapeziometacarpal osteoarthritis treatment using Pyrocardan (R) implants in patients with early Eaton (stage I and II) osteoarthritis. We analyzed the results of 27 patients, with a median age of 59 years (range, 34-78 years) and a mean follow-up of 24 months (range, 12-41). The level of satisfaction was assessed using a postoperative questionnaire. Twenty patients mentioned having improvements in their activities of daily living, 20 patients were satisfied with the outcomes of surgery, and 19 patients would consider undergoing the procedure a second time. Five patients needed reoperation for complications, including persistent pain, grinding, or implant dislocation. Pyrocardan (R) implants may be a valuable temporary therapy as more conventional arthroplasty techniques are still feasible in case of failure. However, multicenter randomized controlled trials with a longer follow-up are needed to assess the long-term outcomes.
AB - The aim of this retrospective study was to assess the early outcomes of trapeziometacarpal osteoarthritis treatment using Pyrocardan (R) implants in patients with early Eaton (stage I and II) osteoarthritis. We analyzed the results of 27 patients, with a median age of 59 years (range, 34-78 years) and a mean follow-up of 24 months (range, 12-41). The level of satisfaction was assessed using a postoperative questionnaire. Twenty patients mentioned having improvements in their activities of daily living, 20 patients were satisfied with the outcomes of surgery, and 19 patients would consider undergoing the procedure a second time. Five patients needed reoperation for complications, including persistent pain, grinding, or implant dislocation. Pyrocardan (R) implants may be a valuable temporary therapy as more conventional arthroplasty techniques are still feasible in case of failure. However, multicenter randomized controlled trials with a longer follow-up are needed to assess the long-term outcomes.
KW - Trapeziometacarpal osteoarthritis
KW - Pyrocarbon
KW - Arthroplasty
KW - Pyrocardan (R) implant
U2 - 10.1016/j.hansur.2016.09.004
DO - 10.1016/j.hansur.2016.09.004
M3 - Article
C2 - 27890249
SN - 2468-1229
VL - 35
SP - 407
EP - 412
JO - Hand Surgery and Rehabilitation
JF - Hand Surgery and Rehabilitation
IS - 6
ER -